Anti-diabetic effect of loganin by inhibiting FOXO1 nuclear translocation via PI3K/Akt signaling pathway in INS-1 cell

Document Type : Original Article


1 Beijing University of Chinese Medicine, Beijing, 100029, China

2 Beijing Open University, Beijing, 100081, China

3 Beijing University of Chinese Medicine, Third Affiliated Hospital, Beijing, 100029, China


Objective(s): JiangTangXiaoKe (JTXK) granule, a Chinese traditional herbal formula, has been clinically used and demonstrated to be beneficial in controlling high glucose and to relieve the symptoms of  Type 2 diabetes mellitus patients for decades. In this study, we explored how loganin, one of the components in JTXK granule, mediated the anti-diabetic effect.
Materials and Methods: We generate a cell model with the dysfunction of insulin secretion by over-expression FOXO1 in INS-1 cells. MTT method was used to detect cytotoxicity after treated with Loganin. ELISA analysis was used to examine insulin secretion. The expression levels of FOXO1 and Akt were evaluated by Western blot.
Results: Treatment with Loganin did not change the expression level of FOXO1 in INS-1 cells, but increased phosphorylation of FOXO1 and inhibited the nuclear translocation and accumulation of FOXO1, which improved the insulin secretion of the cells. Mechanistically, we found PI3K/Akt signaling pathway involved in these effects, which were blocked by an Akt inhibitor, LY294002.
Conclusion: Loganin mediated the subcellular distribution of FOXO1 via PI3K/Akt signaling pathway, which protected the function of insulin secretion in islet INS-1 cells.


Main Subjects

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 2016; 387:1513-1530.
2. Collaborators GRF. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386:2287-2323.
3. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Investig 1999; 104:787-794.
4. Sesti G, Federici M, Lauro D, Sbraccia P, Lauro R. Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms. Diabetes Metab Res Rev 2001; 17:363-373.
5. Singh KA, Devi RKB, Singh KL. B-cell failure and preservation in type 2 diabetes mellitus: a review. J Evolution Med Dent Sci 2016; 5:5315-5321.
6. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Investig 2006; 116:1802-1812.
7. Leibowitz G, Kaiser N, Cerasi E. beta-Cell failure in type 2 diabetes. J Diabetes Investig 2011; 2:82-91.
8. Tsuchiya K, Ogawa Y. Forkhead box class O family member proteins: The biology and pathophysiological roles in diabetes. J Diabetes Investig 2017; 8:726-734.
9. Yang Y, Xu H, Dai Q. Foxo regulates cell proliferation, differentiation and apoptosis. Prog Physiol Sci 2008; 39:362-365.
10. Lu Z, Gan L, Miao H, Wang Z, Zou Q. Foxo1 expression influence proliferation and apoptosis of pancreatic β cells. Chin J Biochem Mol Biol 2009; 25:50-56.
11. Kitamora T, Kitamura YI. Role of foxo proteins in pancreatic β cells. Endocr J 2007; 54:507-515.
12. Huang H, Xia N. Effect of FOXO1 on pancreatic beta cells in diabetes mellitus. Intel Med Chin 2009; 4:404-407.
13. Pajvani UB, Accili D. The new biology of diabetes. Diabetologia 2015; 58:2459-2468.
14. Rutter GA, Pullen TJ, Hodson DJ, Martinez-Sanchez A. Pancreatic β-cell identity, glucose sensing and the control of insulin secretion. Biochem J 2015; 466:203-218.
15. Kim SJ, Winter K, Nian C, Tsuneoka M, Koda Y, McIntosh CH. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 2005; 280:22297-22307.
16. Ma Y, Wang X, Peng Y, Ding X. Forkhead box O1 promotes INS1 cell apoptosis by reducing the expression of CD24. Mol Med Rep 2016; 13:2991-2998.
17. Gao S, Gong Y, Ni Q, Luo Z, Zhao J, Gao Y, et al.  Clinical study on treatment of type 2 diabetes from aspects of liver, spleen and kidney. J Tradit Chin Med 2009; 24:1007-1010.
18. Zhao D, Li X, Yu N, Fang X, Mu Q, Qin P, et al.  Effect of Jiangtang xiaoke granule on glucose and lipid metabolism in type 2 diabetic rats. Chin J Exp Trad Med Form 2013; 19:172-176.
19. Zhang Y, Yu N, Mu Q, Zhao D, Zuo J, An H, et al.  Effect of Jiangtang xiaoke granule on hepatic lipid metabolism in type 2 diabetic KKAy mice. J Tradit Chin Med 2016; 34:2626-2629.
20. Guerra SD, Lupi R, Marselli L, Masini M, Bugliani M, Sbrana S, et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005; 54:727-735.
21. Kim HJ, Kobayashi M, Sasaki T, Kikuchi O, Amano K, Kitazumi T, et al.  Overexpression of FoxO1 in the hypothalamus and pancreas causes obesity and glucose intolerance. Endocrinology 2012; 153:659-671.
22. Nakae J, Cao Y, Hakuno F, Takemori H, Kawano Y, Sekioka R, et al.  Novel repressor regulates insulin sensitivity through interaction with foxo1. EMBO J 2012; 31:2275-2295.
23. Wu R, Zhao D, Fang X, Gao S. Effects of Jiangtang xiaoke granule-containing serum on apoptosis of INS-1 cells. J Tradit Chin Med 2016; 34:2090-2092.
24. Shu T, Zhu Y, Wang H, Lin Y, Ma Z, Han X. AGEs decrease insulin synthesis in pancreatic b-cell by repressing Pdx-1 protein expression at the post-ttranslational level. PLoS One 2011; 6:18782-18789.
25. Sathanoori R, Olde B, Erlinge D, Goransson O, Wierup N. Cocaine- and amphetamine-regulated transcript (CART) protects beta cells against glucotoxicity and increases cell proliferation. J Biol Chem 2013; 288:3208-3218.
26. Wang Y, Lin H, Hao N, Zhu Z, Wang D, Li Y, et al. Forkhead box O1 mediates defects in palmitate-induced insulin granule exocytosis by downregulation of calcium/calmodulin-dependent serine protein kinase expression in INS-1 cells. Diabetologia 2015; 58:1272-1281.